Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | United States Department of Health and Human Services | 22 |
| 2 | Battelle Energy Alliance LLC | 17 |
| 3 | Danisco US Inc | 14 |
| 4 | F Hoffmann La Roche AG | 13 |
| 5 | Merck and Co Inc | 12 |
| 6 | Roche Diagnostics GmbH | 10 |
| 7 | Yeda Research and Development Co Ltd | 10 |
| 8 | Lipotec SA | 8 |
| 9 | Cellectar Biosciences Inc | 6 |
| 10 | CS Pharmatech Ltd | 5 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07K | Peptides | 154 |
| 2 | A61K | Medicinal preparations | 146 |
| 3 | A61P | Therapeutic activity (drug indications) | 121 |
| 4 | G01N | Investigating / analysing materials | 90 |
| 5 | C12N | Microorganisms, enzymes | 74 |
| 6 | C07D | Heterocyclic compounds | 52 |
| 7 | C12Q | Measuring/testing involving enzymes | 41 |
| 8 | C12P | Fermentation, enzyme processes | 31 |
| 9 | C07C | Acyclic and carbocyclic compounds | 22 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 21 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Crystallography and molecular interactions | 1 |
| 2 | Enzyme Structure and Function | 1 |
| 3 | Trace Elements in Health | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | F. Ann Walker | University of Arizona | 3 |
| 2 | Anthony R. Clarke | University College London | 2 |
| 3 | C. Jeremy Craven | University of Sheffield | 2 |
| 4 | Glenn L. Millhauser | University of California, Santa Cruz | 2 |
| 5 | Graham S. Jackson | University College London | 2 |
| 6 | Huilu Wu | Lanzhou Jiaotong University | 2 |
| 7 | John Collinge | University College London | 2 |
| 8 | Jonathan P. Waltho | University of Sheffield | 2 |
| 9 | Laszlo L. P. Hosszu | University of Sheffield | 2 |
| 10 | M A Wells | University of Sheffield | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Molecular Features of the Copper Binding Sites in the Octarepeat Domain of the Prion Protein | 2002 | 417 | Trace Elements in Health |
| Histidine phosphorylation in biological systems | 2007 | 91 | Enzyme Structure and Function |
| Direct Evidence That All Three Histidine Residues Coordinate to Cu(II) in Amyloid-β1−16 | 2008 | 84 | Protein Structure and Dynamics |
| Mechanism of copper(II)-induced misfolding of Parkinson's disease protein | 2011 | 84 | Parkinson's Disease Mechanisms and Treatments |
| Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4 | 2006 | 83 | Trace Elements in Health |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of this compound?
Which organizations hold the most patents related to this compound?
What are the primary patent classification areas for inventions involving this compound?
What research topics are associated with this compound in published literature?
What was the patent activity trend in recent years?